Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionBispecific antibody targeting carcinoembryonic antigen (CEA) and the CD3 receptor
Molecular Target Carcinoembryonic antigen (CEA) ; CD3
Mechanism of ActionBispecific antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat CEA expressing solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today